This study also showed trends in the reduction of cardiovascular mortality and a composite end-point of bleeding, stroke, and thromboembolism with warfarin use but these did not reach statistical significance [ 13 ].
← all excerpts
Stroke Prophylaxis in Patients with Atrial Fibrillation and End-Stage Renal Disease.
1
—
—